Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with patients’ neurological function. Methods: Admitted between April 2019 and January 2022, 49 patients with pathologically confirmed GL and 42...
Saved in:
Published in | Frontiers in behavioral neuroscience Vol. 16; p. 957795 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Lausanne
Frontiers Research Foundation
06.09.2022
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
ISSN | 1662-5153 1662-5153 |
DOI | 10.3389/fnbeh.2022.957795 |
Cover
Loading…
Abstract | Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with patients’ neurological function. Methods: Admitted between April 2019 and January 2022, 49 patients with pathologically confirmed GL and 42 cases with MTB were selected as the subjects for retrospective analysis. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC) and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental State Examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed. Results: The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P>0.05), but the FA value of the parenchyma area of GL was higher (P0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P<0.05). In GL and MTB patients, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P<0.05). Conclusion: Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients. |
---|---|
AbstractList | ObjectiveTo determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients’ neurological function.MethodsA retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed.ResultsThe clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and Ktrans values (P > 0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05).ConclusionContrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients. To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients' neurological function.ObjectiveTo determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients' neurological function.A retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients' neurological dysfunction was observed.MethodsA retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients' neurological dysfunction was observed.The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and Ktrans values (P > 0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05).ResultsThe clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and Ktrans values (P > 0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05).Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.ConclusionContrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients. Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with patients’ neurological function. Methods: Admitted between April 2019 and January 2022, 49 patients with pathologically confirmed GL and 42 cases with MTB were selected as the subjects for retrospective analysis. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC) and operation coefficient (Ktrans) were calculated by taking the tumor parenchyma area, cystic area and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental State Examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed. Results: The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P>0.05), but the FA value of the parenchyma area of GL was higher (P0.05), while the former presented lower ADC values and higher Ktrans values of the peritumor edema area than the latter (P<0.05). In GL and MTB patients, the FA and Ktrans values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P<0.05). Conclusion: Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients. |
Author | Xie, Lizhi Shi, Zhuo Zhao, Xinming Jiang, Jiuming |
AuthorAffiliation | 1 Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China 2 GE Healthcare, MR Research China , Beijing , China |
AuthorAffiliation_xml | – name: 2 GE Healthcare, MR Research China , Beijing , China – name: 1 Department of Imaging Diagnosis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China |
Author_xml | – sequence: 1 givenname: Zhuo surname: Shi fullname: Shi, Zhuo – sequence: 2 givenname: Jiuming surname: Jiang fullname: Jiang, Jiuming – sequence: 3 givenname: Lizhi surname: Xie fullname: Xie, Lizhi – sequence: 4 givenname: Xinming surname: Zhao fullname: Zhao, Xinming |
BookMark | eNp1ks1u1DAUhSNUJNrCA7CzxIZNBsfxT7JBQlWBSpXYwNpy7OuMR4k92E6hu74Gr8Rj8CQ4MwXRSqxsHZ_zXfv6nlUnPnioqpcN3rRt17-xfoDthmBCNj0TomdPqtOGc1KzhrUn_-yfVWcp7TDmhFNxWv28tNZppW8R3KhpUdkFj4JFOvgcVco1-K3yGgya1eghO40ipOBXDbmiOT8i55Fx1kIEn11BFGmcXJgVsjHMaIZcSGrN5mUOceXnLaAhqpJU3iD4vp9C_Fvc5YRUSkG7o_TN5S3al33hp193P5CHJYYpjOXmE7KL16vtefXUqinBi_v1vPry_vLzxcf6-tOHq4t317WmAudaWdFwRoduMAO3RmPgoCllbGh5RzTRdmAN7wTtTGNUb5u24bQ3nSCWMsxMe15dHbkmqJ3cx9KFeCuDcvIghDhKFctjJ5Cacm257kjfctoNTPXadm1viOWUM6sK6-2RtV-GGYyGtevTA-jDE--2cgw3sqcdxz0pgNf3gBi-LpCynF3SME3KQ1iSJKIRvJTkolhfPbLuwhJ9adXqwphwJnhxiaNLx5BSBCu1y4dvKPXdJBss14GTh4GT68DJ48CVZPMo-ecZ_8_8Bn5L5Lk |
CitedBy_id | crossref_primary_10_1016_j_acra_2024_06_006 crossref_primary_10_1007_s10278_024_01026_9 crossref_primary_10_13104_imri_2022_26_4_256 |
Cites_doi | 10.1007/s00330-019-06548-3 10.1016/j.nucmedbio.2021.02.003 10.1002/jmri.26611 10.1016/j.nec.2018.08.008 10.1111/jon.12281 10.1126/scitranslmed.aba2591 10.1016/j.jocn.2020.04.051 10.1038/s41598-021-90032-w 10.1186/s13014-019-1228-x 10.18632/oncotarget.11114 10.2174/1573405617666210316120314 10.12968/hmed.2019.80.7.380 10.2463/mrms.2014-0129 10.1016/j.wneu.2020.09.113 10.1016/j.semcancer.2017.11.010 10.1186/s12880-020-00488-x 10.23736/S0390-5616.20.05112-7 10.1016/j.canlet.2020.02.025 10.1007/s11060-020-03499-4 10.1038/s41582-021-00510-y 10.1158/2159-8290.CD-20-1474 10.1016/j.canlet.2020.02.002 |
ContentType | Journal Article |
Copyright | 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2022 Shi, Jiang, Xie and Zhao. Copyright © 2022 Shi, Jiang, Xie and Zhao. 2022 Shi, Jiang, Xie and Zhao |
Copyright_xml | – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2022 Shi, Jiang, Xie and Zhao. – notice: Copyright © 2022 Shi, Jiang, Xie and Zhao. 2022 Shi, Jiang, Xie and Zhao |
DBID | AAYXX CITATION 3V. 7QG 7QP 7QR 7TK 7XB 88I 8FD 8FE 8FH 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M2P M7P P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PSYQQ Q9U 7X8 5PM DOA |
DOI | 10.3389/fnbeh.2022.957795 |
DatabaseName | CrossRef ProQuest Central (Corporate) Animal Behavior Abstracts Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database ProQuest Central Student SciTech Premium Collection ProQuest Biological Science Collection Science Database (ProQuest) Biological Science Database (ProQuest) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences Natural Science Collection ProQuest Central Korea Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Animal Behavior Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1662-5153 |
ExternalDocumentID | oai_doaj_org_article_c46cf6c8293648b5a9cf839d2f6465fa PMC9486092 10_3389_fnbeh_2022_957795 |
GroupedDBID | --- 29H 2WC 53G 5GY 5VS 8FE 8FH 9T4 AAFWJ AAYXX ABIVO ABUWG ACGFO ACGFS ACIWK ACPRK ACXDI ADBBV ADRAZ AEGXH AENEX AFKRA AFPKN AIAGR ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CITATION CS3 DIK E3Z EMOBN F5P GROUPED_DOAJ GX1 HCIFZ HYE KQ8 LK8 M2P M48 M7P M~E O5R O5S OK1 OVT PGMZT PIMPY PQQKQ PROAC PSYQQ RNS RPM TR2 3V. 7QG 7QP 7QR 7TK 7XB 88I 8FD 8FK CCPQU DWQXO FR3 GNUQQ P64 PHGZM PHGZT PKEHL PQEST PQGLB PQUKI Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c470t-af71654b8bdb6fdc0e6ec4455b3682c2cfb5168748d1da9f131649d872f4505d3 |
IEDL.DBID | M48 |
ISSN | 1662-5153 |
IngestDate | Wed Aug 27 01:32:55 EDT 2025 Thu Aug 21 18:39:59 EDT 2025 Fri Jul 11 12:16:54 EDT 2025 Mon Jun 30 09:38:10 EDT 2025 Tue Jul 01 01:14:13 EDT 2025 Thu Apr 24 23:01:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c470t-af71654b8bdb6fdc0e6ec4455b3682c2cfb5168748d1da9f131649d872f4505d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Reviewed by: Fenglong Sun, Capital University of Medical Sciences, China; Yang Liu, The First Medical Center of Chinese PLA General Hospital, China This article was submitted to Emotion Regulation and Processing, a section of the journal Frontiers in Behavioral Neuroscience Edited by: Fenglin Liu, Korea University of Technology and Education, South Korea |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnbeh.2022.957795 |
PQID | 2710026576 |
PQPubID | 2046456 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c46cf6c8293648b5a9cf839d2f6465fa pubmedcentral_primary_oai_pubmedcentral_nih_gov_9486092 proquest_miscellaneous_2717683967 proquest_journals_2710026576 crossref_citationtrail_10_3389_fnbeh_2022_957795 crossref_primary_10_3389_fnbeh_2022_957795 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-06 |
PublicationDateYYYYMMDD | 2022-09-06 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-06 day: 06 |
PublicationDecade | 2020 |
PublicationPlace | Lausanne |
PublicationPlace_xml | – name: Lausanne |
PublicationTitle | Frontiers in behavioral neuroscience |
PublicationYear | 2022 |
Publisher | Frontiers Research Foundation Frontiers Media S.A |
Publisher_xml | – name: Frontiers Research Foundation – name: Frontiers Media S.A |
References | Priya (B16) 2021; 11 Majigsuren (B13) 2016; 15 Nicholson (B15) 2021; 11 Tsiouris (B20) 2019; 22 Mueller (B14) 2020 Almansory (B2) 2019; 80 Li (B12) 2020; 20 Smits (B18) 2021; 17 Gusyatiner (B6) 2018; 51 Tepe (B19) 2021; 17 Abecassis (B1) 2020; 76 Harisinghani (B7) 2019; 11 Hu (B8) 2020; 477 Vallejo-Armenta (B21) 2021 Gannon (B4) 2019; 49 Kim (B11) 2020; 30 Furuse (B3) 2019; 14 Xu (B23) 2020; 476 Przybylowski (B17) 2021; 151 Jin (B9) 2021; 149 Jung (B10) 2016; 26 Gao (B5) 2016; 7 Wang (B22) 2019; 30 |
References_xml | – volume: 30 start-page: 2142 year: 2020 ident: B11 article-title: Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. publication-title: Eur. Radiol. doi: 10.1007/s00330-019-06548-3 – start-page: 1 year: 2021 ident: B21 article-title: [(99m)Tc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas. publication-title: Nuclear Med. Biol. doi: 10.1016/j.nucmedbio.2021.02.003 – volume: 49 start-page: e122 year: 2019 ident: B4 article-title: State of the art: Evaluation and prognostication of myocarditis using cardiac MRI. publication-title: J. Magn. Reson. Imaging doi: 10.1002/jmri.26611 – volume: 30 start-page: 111 year: 2019 ident: B22 article-title: Low-grade glioma radiotherapy treatment and trials. publication-title: Neurosurg. Clin. N. Am. doi: 10.1016/j.nec.2018.08.008 – volume: 26 start-page: 240 year: 2016 ident: B10 article-title: Comparison of glioblastomas and brain metastases using dynamic contrast-enhanced perfusion MRI. publication-title: J. Neuroimaging. doi: 10.1111/jon.12281 – volume: 11 year: 2019 ident: B7 article-title: Advances in clinical MRI technology. publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aba2591 – volume: 76 start-page: 46 year: 2020 ident: B1 article-title: Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imaging. publication-title: J. Clin. Neurosci. doi: 10.1016/j.jocn.2020.04.051 – volume: 11 year: 2021 ident: B16 article-title: Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics. publication-title: Sci. Rep. doi: 10.1038/s41598-021-90032-w – volume: 14 year: 2019 ident: B3 article-title: Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: A systematic review. publication-title: Radiat. Oncol. doi: 10.1186/s13014-019-1228-x – volume: 7 start-page: 71330 year: 2016 ident: B5 article-title: Circulating tumor cell is a common property of brain glioma and promotes the monitoring system. publication-title: Oncotarget doi: 10.18632/oncotarget.11114 – volume: 17 start-page: 1200 year: 2021 ident: B19 article-title: The potential role of peritumoral apparent diffusion coefficient evaluation in differentiating glioblastoma and solitary metastatic lesions of the brain. publication-title: Curr. Med. Imaging doi: 10.2174/1573405617666210316120314 – volume: 80 start-page: 380 year: 2019 ident: B2 article-title: Combined PET/MRI in brain glioma imaging. publication-title: Br. J. Hosp. Med. (Lond) doi: 10.12968/hmed.2019.80.7.380 – volume: 15 start-page: 34 year: 2016 ident: B13 article-title: Comparison of brain tumor contrast-enhancement on T1-CUBE and 3D-SPGR images. publication-title: Magn. Reson. Med. Sci. doi: 10.2463/mrms.2014-0129 – volume: 149 start-page: 325 year: 2021 ident: B9 article-title: Brain glioma localization diagnosis based on magnetic resonance imaging. publication-title: World Neurosurg. doi: 10.1016/j.wneu.2020.09.113 – volume: 51 start-page: 50 year: 2018 ident: B6 article-title: Glioma epigenetics: From subclassification to novel treatment options. publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2017.11.010 – volume: 20 year: 2020 ident: B12 article-title: Solitary vertebral metastatic glioblastoma in the absence of primary brain tumor relapse: A case report and literature review. publication-title: BMC Med. Imaging doi: 10.1186/s12880-020-00488-x – year: 2020 ident: B14 article-title: Enzymatic activity of extracellular circulating proteasome in the CSF of patients with malignant intrinsic and metastatic brain tumors: Proof of concept. publication-title: J. Neurosurg. Sci. doi: 10.23736/S0390-5616.20.05112-7 – volume: 22 start-page: 206 year: 2019 ident: B20 article-title: Principles and current trends in the correlative evaluation of glioma with advanced MRI techniques and PET. publication-title: Hell. J. Nuclear Med. – volume: 477 start-page: 97 year: 2020 ident: B8 article-title: Imaging of intratumoral heterogeneity in high-grade glioma. publication-title: Cancer Lett. doi: 10.1016/j.canlet.2020.02.025 – volume: 151 start-page: 491 year: 2021 ident: B17 article-title: Surgical strategy for insular glioma. publication-title: J. Neurooncol. doi: 10.1007/s11060-020-03499-4 – volume: 17 start-page: 486 year: 2021 ident: B18 article-title: MRI biomarkers in neuro-oncology. publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-021-00510-y – volume: 11 start-page: 575 year: 2021 ident: B15 article-title: Diffuse glioma heterogeneity and its therapeutic implications. publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-20-1474 – volume: 476 start-page: 1 year: 2020 ident: B23 article-title: Immunotherapy for glioma: Current management and future application. publication-title: Cancer Lett. doi: 10.1016/j.canlet.2020.02.002 |
SSID | ssj0062647 |
Score | 2.315352 |
Snippet | Objective: To determine the efficacy of contrast-enhanced MRI in differentiating gliomas (GL) from metastatic tumor of the brain (MTB) and its association with... To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with... ObjectiveTo determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 957795 |
SubjectTerms | Anisotropy apparent diffusion coefficient Brain tumors Diffusion coefficient Disease Edema fractional anisotropy Glioma Ktrans Magnetic resonance imaging Metastases Metastasis metastatic tumor of brain MRI Neuroimaging Neurological complications Neuroscience Parenchyma Patients Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQT1wQUBCBggYJcUAKzTqOnRwLalUhwYlKvUX-bVdqHNTNHnrra_BKPEafpDNOdru5wIVLDomdOJ6J55t45hvGPihXCGJtyW0hNaXkqNyEssJDUbi69Non2sXvP-Tpmfh2Xp3vlPqimLCRHnicuEMrpA3S1miWpKhNpRsb0Kg7HqSQVUjQCG3expka12BE6UKNe5jogjWHIRpPOw-cf24qpaiYxI4VSmT9M4Q5j4_cMTgnT9mTCSnC0TjCZ-yRj8_Z_lFEL7m7gY-QYjfTT_F99ueYmCC0vYEH9m7oA6RAdL0ach8v01Y_dPoiUt4ioJvdE9mGh2WXKhXBMsKmXMpAAsNTF1fLvtNAOSjQ-UFT-hH2HdZdf033R_QIhopMgI4OfIrn2z58OaxAP0gf6JcvTDyuq7vb35C4NKe1F8jAUrMX7Ozk-OfX03yq0pBboYoh10FRRpSpDWX0OVt46a0QVWVKWXPLbTDVQtZK1G7hdBMWJXpojasVDwLhlytfsr3YR_-KQW1LAniWE7ArtDGuqApuZSO5VghcMlZspNbaicKcKmlctejKkKDbJOiWBN2Ogs7Yp22XXyN_x98afyFV2DYk6u10AhWynRSy_ZdCZuxgo0jttB6sWk4kSlyic5ex99vL-CXT9oyOvl-nNuj7lY1UGVMzBZwNaH4lLi8TJ3hDxcQa_vp_vMEb9pgmJUXSyQO2N1yv_VuEXoN5l76ye61aNYo priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagvXBBQEEsFDRIiANSaNZx7OSEWrRVhUSFEJV6i_y7jdQ4ZTd76I3X4JV4DJ4Ej9e721x6ySFx_jTj8TeemW8IeS9MzpC1JdM5l1iSIzLlijIc8txUhZU20i5-O-dnF-zrZXmZNtyWKa1yYxOjoTa9xj3yI4o0NJQHePz55leGXaMwuppaaDwk-8EEV8H52j-ZnX__sbHFAa0zsY5lBlesPnJeWYxAUPqpLoXAphJ3VqNI2j9CmuM8yTsLz-kT8jghRjhei_gpeWD9M3Jw7IO33N3CB4g5nHFz_ID8nSEjhNS3sGPxht5BTEiXyyGz_iqG_KGTc4_1ixDc7R5JNyy0XexYBK2HTduUAQUXTs2v276TgLUo0NlBYhlSuHdYdf0Cnx9QJChsNgHSG7Axr2_78nZYgtxpAeDWLyQ-1-W_338gcmomGwy40OKw5-TidPbzy1mWujVkmol8yKQTWBmlKoWVfUbnllvNWFmqgldUU-1UOeWVYJWZGlm7aRE8tdpUgjoWYJgpXpA933v7kkClCwR6miLAy6VSJi9zqnnNqRQBwExIvpFaoxOVOXbUuG6CS4OCbqKgGxR0sxb0hHzc3nKz5vG4b_AJqsJ2IFJwxxP9Yt6kGd1oxrXjugp4ibNKlbLWLqBNQx1nvHRyQg43itQku7Bsdlo8Ie-2l8OMxjCN9LZfxTHBByxqLiZEjBRw9EHjK769itzgNTYVq-mr-1_-mjzC3425cvyQ7A2LlX0TwNWg3qYZ9B8Zey4V priority: 102 providerName: ProQuest |
Title | Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function |
URI | https://www.proquest.com/docview/2710026576 https://www.proquest.com/docview/2717683967 https://pubmed.ncbi.nlm.nih.gov/PMC9486092 https://doaj.org/article/c46cf6c8293648b5a9cf839d2f6465fa |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwELbG9sILGgxEYVSHhHhAykgdx04eENpQx4S0CSEq9S2yHbuL1DjQptL6xt_gL_Ez-CX43LQj0sQDL3lI7LbK3fW-8919R8grUcYMWVsiHXOJLTkiUjZJ_SWOyywx0gTaxcsrfjFhn6bpdI9sx1t1L3B5Z2iH86Qmi_nJzff1e2_w7zDi9P72rXXKYF6B0pM8FSJP75ED75gE2ukl2yUVPHRnYpPYvHtbzzUFBv8e7OwXTf7lhc4PyYMOPsLpRt4PyZ5xj8jRqfOhc72G1xAKOsNJ-RH5NUZ6CKnXcEvpDY2FUJ0ul21k3HXI_0MtZw6bGcHH3g0ycBio6jC-CCoH2xkqLUrR35rNq6aWgI0pUJtWYk-S39uu6maBn-8hJSicPAHSlWBCkd_uy6t2CfJWJQDPgaEjd13-_vETAsFm94cM6HVx2WMyOR9__XARdaMbIs1E3EbSCmyTUpnCNr9Sx4YbzViaqoRnVFNtVTrimWBZOSplbkeJD9vyMhPUMo_JyuQJ2XeNM08JZDpB1Kcpor1YKlXGaUw1zzmVwqOZAYm3Uit0x2uO4zXmhY9vUNBFEHSBgi42gh6QN7st3zakHv9afIaqsFuIfNzhRrOYFZ15F5pxbbnOPHjiLFOpzLX10LOkljOeWjkgx1tFKrY6XlBkVqLcR3wD8nL32Js35mykM80qrPEBYZJzMSCip4C9H9R_4qrrQBSe44SxnD77753PyX18E6Gmjh-T_XaxMi88CGvVkBycja8-fxmGQwx__TgdDYO5_QEf7T-6 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6V9AAXBBRESoFBAg5Ips56vWsfEGohVUrbCKFW6s2sd9dppHpdEkcoN16Dl-BBeAyehJ2NnTSX3nrJwV7_RDM7_mZ35vsIeS10yJC1JVAhl9iSI4K8iGL3E4Y6iYw0nnbxZMgHZ-zLeXy-Qf60vTBYVtnGRB-odaVwjXyXIg0N5Q4ef7z6EaBqFO6uthIaC7c4MvOfLmWbfjj87Oz7htKD_umnQdCoCgSKibAOZCGwgydPcuxA0yo03CjG4jiPeEIVVUUe93giWKJ7WqZFL3IZRaoTQQvm4IKO3H3vkE0WuVSmQzb3-8Ov39rY77IDJhZ7py71S3cLmxvc8aD0fRoLgSIW175-XiRgDdmu12Ve-9AdPCD3G4QKewuXekg2jH1Etvasy87LObwFXzPqF-O3yN8-MlBINYcVazhUBfgCeDmtA2MvfIkBlHJksV8SXHpfIcmHgXHpFZJgbKGVaanRUdyh0eW4KiVg7wuUppbY9uSurWdlNcH7O9QKOYpbgLQajK8jXD58XE9BrrwOcKkZGv7Y6b9fv8FzeDYxH_DDjsMek7NbseMT0rGVNU8JJCpCYKkoAspQ5rkO45AqnnIqhQNMXRK2VstUQ52OCh6XmUuh0NCZN3SGhs4Whu6Sd8tLrha8ITcN3kdXWA5Eym9_oJqMsiaCZIpxVXCVOHzGWZLHMlWFQ7eaFpzxuJBdstM6UtbEoWm2mjVd8mp52kUQ3BaS1lQzP8blnFHKRZeINQdce6H1M3Z84bnIUxQxS-n2zQ9_Se4OTk-Os-PD4dEzcg__uq_T4zukU09m5rkDdnX-oplNQL7f9gT-DzcsatA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VVEJcEFAQgQKDBByQTJy1vWsfEGppopZCVCEq9WbW6900Um2XxBHKjdfgVXgEHoMnYWZjJ82lt15ysNc_0czOfuOd-T7GXsncD4m1xdO-UNSSI73MBhH--H4eB0YZR7v4ZSQOT8NPZ9HZFvvT9sJQWWUbE12gzitN38h7nGhouEB43LNNWcTJwfDD5Q-PFKRop7WV01i6yLFZ_MT0bfb-6ABt_Zrz4eDbx0OvURjwdCj92lNWUjdPFmfUjZZr3wijwzCKskDEXHNts6gvYhnGeT9Xie0HmF0keSy5DRE65AHe9xbblpgV-R22vT8YnXxt1wHMFEK53EfFNDDp2TIztPvB-bskkpIELa6shE4wYAPlbtZoXln0hvfY3Qatwt7Sve6zLVM-YDt7JWbqxQLegKsfdR_md9jfAbFRKL2ANYM4VBZcMbya1Z4pz125ARRqXFLvJGCqXxHhh4FJ4dSSYFJCK9lSk9PgofHFpCoUUB8MFKZW1AKF19bzoprS_RHBQkZCF6DKHIyrKVw9fFLPQK09EOizMzRcsrN_v36D4_Ns4j_QIk_DHrLTG7HjI9Ypq9I8ZhDrgECm5gQufZVluR_5XItEcCURPHWZ31ot1Q2NOql5XKSYTpGhU2folAydLg3dZW9Xl1wuOUSuG7xPrrAaSPTf7kA1HadNNEl1KLQVOkasJsI4i1SiLSLdnFsRisiqLtttHSltYtIsXc-gLnu5Oo3RhLaIVGmquRuD-WeQCNllcsMBN15o80w5OXe85AkJmiX8yfUPf8Fu48RNPx-Njp-yO_TPXcme2GWdejo3zxDj1dnzZjIB-37T8_c_nLNvBQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+evaluation+of+contrast-enhanced+magnetic+resonance+imaging+in+differentiating+glioma+from+metastatic+tumor+of+the+brain+and+exploration+of+its+association+with+patients%E2%80%99+neurological+function&rft.jtitle=Frontiers+in+behavioral+neuroscience&rft.au=Shi%2C+Zhuo&rft.au=Jiang%2C+Jiuming&rft.au=Xie%2C+Lizhi&rft.au=Zhao%2C+Xinming&rft.date=2022-09-06&rft.pub=Frontiers+Media+S.A&rft.eissn=1662-5153&rft.volume=16&rft_id=info:doi/10.3389%2Ffnbeh.2022.957795&rft.externalDocID=PMC9486092 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-5153&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-5153&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-5153&client=summon |